Arbaclofen Extended-Release Tablets

arbaclofen · RVL Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Arbaclofen Extended-Release Tablets, covering 2022-07-15 to 2022-07-15. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate the Safety and Effectiveness of Arbaclofen Extended-Release Tablets for Patients With MS [Phase 3]

See pricing